Molecular and Imaging Studies of Cardiovascular Health and Disease
NCT ID: NCT02804269
Last Updated: 2016-06-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
5000 participants
OBSERVATIONAL
2013-07-31
2033-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiovascular Health Improvement Project
NCT02306200
Metabolomic Study of All-age Cardiomyopathy
NCT03061994
Efficiency and Outcomes of Stress-Only Anger and D-SPECT Stress-Only SPECT MPI
NCT01373944
a Foundational Model for Cardiovascular Disease Diagnosis and Prediction
NCT06591923
An Integrative-"Omics" Study of Cardiomyopathy Patients for Diagnosis and Prognosis in China
NCT03076580
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Volunteer
Subjects will undergo the following study procedure: Cardiovascular Magnetic Resonance Imaging and fatmass measurement
Cardiovascular Magnetic Resonance
For the evaluation of heart function and structure of the cardiovascular system.
Fatmass measurement
It utilizes a scale machine to measure the body fat and skeletal muscle percentage
Dilated Cardiomyopathy
Subjects will undergo the following study procedure: Cardiovascular Magnetic Resonance Imaging and fatmass measurement
Cardiovascular Magnetic Resonance
For the evaluation of heart function and structure of the cardiovascular system.
Fatmass measurement
It utilizes a scale machine to measure the body fat and skeletal muscle percentage
Hypertrophic cardiomyopathy
Subjects will undergo the following study procedure: Cardiovascular Magnetic Resonance Imaging and fatmass measurement
Cardiovascular Magnetic Resonance
For the evaluation of heart function and structure of the cardiovascular system.
Fatmass measurement
It utilizes a scale machine to measure the body fat and skeletal muscle percentage
Ischemic heart disease with reduced EF
Subjects will undergo the following study procedure: Cardiovascular Magnetic Resonance Imaging and fatmass measurement
Cardiovascular Magnetic Resonance
For the evaluation of heart function and structure of the cardiovascular system.
Fatmass measurement
It utilizes a scale machine to measure the body fat and skeletal muscle percentage
Ischemic heart disease with normal EF
Subjects will undergo the following study procedure: Cardiovascular Magnetic Resonance Imaging and fatmass measurement
Cardiovascular Magnetic Resonance
For the evaluation of heart function and structure of the cardiovascular system.
Fatmass measurement
It utilizes a scale machine to measure the body fat and skeletal muscle percentage
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiovascular Magnetic Resonance
For the evaluation of heart function and structure of the cardiovascular system.
Fatmass measurement
It utilizes a scale machine to measure the body fat and skeletal muscle percentage
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
16 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart Centre Singapore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stuart Cook, MBBS,PhD
Role: PRINCIPAL_INVESTIGATOR
National Heart Centre Singapore
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Heart Centre Singapore
Singapore, Singapore, Singapore
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Stuart Cook, MBBS, PhD
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013/605/C
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.